Chabiotech Co.,Ltd.

KOSDAQ:A085660 Stock Report

Market Cap: ₩843.0b

ChabiotechLtd Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for ChabiotechLtd.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Healthcare earnings growth18.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Is ChabiotechLtd (KOSDAQ:085660) Using Too Much Debt?

Nov 12
Is ChabiotechLtd (KOSDAQ:085660) Using Too Much Debt?

Chabiotech Co.,Ltd.'s (KOSDAQ:085660) Shares Lagging The Industry But So Is The Business

Aug 07
Chabiotech Co.,Ltd.'s (KOSDAQ:085660) Shares Lagging The Industry But So Is The Business

Is CHA Biotech (KOSDAQ:085660) Using Too Much Debt?

Mar 01
Is CHA Biotech (KOSDAQ:085660) Using Too Much Debt?

If You Had Bought CHA Biotech's (KOSDAQ:085660) Shares Three Years Ago You Would Be Down 52%

Jan 25
If You Had Bought CHA Biotech's (KOSDAQ:085660) Shares Three Years Ago You Would Be Down 52%

The Trends At CHA Biotech (KOSDAQ:085660) That You Should Know About

Dec 21
The Trends At CHA Biotech (KOSDAQ:085660) That You Should Know About

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as ChabiotechLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A085660 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/20241,009,799-2,600-111,953-10,007N/A
6/30/2024974,803-23,278-98,93214,156N/A
3/31/2024949,922-27,916-92,22419,074N/A
12/31/2023953,951-8,431-60,41313,018N/A
9/30/2023942,431-31,870-81,649-7,693N/A
6/30/2023921,073-39,266-94,985-12,243N/A
3/31/2023892,981-37,037-135,981-31,026N/A
12/31/2022844,583-47,543-148,091-19,399N/A
9/30/2022808,777-4,922-94,67634,321N/A
6/30/2022779,374602-122,71419,076N/A
3/31/2022747,666-21,366-105,93123,170N/A
12/31/2021727,476-13,968-89,20726,248N/A
9/30/2021704,072-26,755-141,236-22,020N/A
6/30/2021694,812-31,561-108,91419,981N/A
3/31/2021677,277-16,194-60,37763,972N/A
12/31/2020664,717-18,658-82,21946,996N/A
9/30/2020655,853-7,667-65,52561,913N/A
6/30/2020590,893-8,520-49,54868,900N/A
3/31/2020565,52949,125-90,74526,646N/A
12/31/2019534,61246,375-86,55225,239N/A
9/30/2019500,91046,386-84,13227,260N/A
6/30/2019515,23251,595-53,56441,876N/A
3/31/2019502,20119,23118,16171,150N/A
12/31/2018488,60024,698-4,20575,384N/A
9/30/2018502,3601,51632,45695,182N/A
6/30/2018467,869-12,462N/A42,232N/A
3/31/2018435,256-37,872N/A10,816N/A
12/31/2017417,460-45,585N/A12,009N/A
9/30/2017402,155-20,436N/A-15,438N/A
6/30/2017416,750-9,272N/A1,788N/A
3/31/2017434,6691,024N/A9,577N/A
12/31/2016449,26111,448N/A11,294N/A
9/30/2016428,117-6,336N/A26,633N/A
6/30/2016423,770-8,274N/A44,737N/A
3/31/2016410,812-10,394N/A72,600N/A
12/31/2015393,782-14,956N/A61,863N/A
9/30/2015424,0741,805N/A56,686N/A
6/30/2015386,370-562N/A35,157N/A
3/31/2015361,625-2,257N/A-5,329N/A
12/31/2014345,345-4,721N/A-2,568N/A
9/30/2014298,626-12,157N/A15,129N/A
6/30/2014323,263-5,312N/A25,504N/A
3/31/2014370,7494,712N/A56,720N/A
12/31/2013386,83511,308N/A66,353N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A085660's forecast earnings growth is above the savings rate (2.7%).

Earnings vs Market: Insufficient data to determine if A085660's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A085660's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A085660's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A085660's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if A085660's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y